From Wikipedia, the free encyclopedia
Chemical compound
FUB-144
Legal status
[1-(4-Fluorobenzyl)-1H -indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
CAS Number
PubChem
CID
ChemSpider
UNII
CompTox Dashboard (
EPA )
Formula C 23 H 24 F N O
Molar mass 349.449 g·mol−1 3D model (
JSmol )
Fc1ccc(cc1)Cn1cc(c2c1cccc2)C(=O)C1C(C1(C)C)(C)C
InChI=1S/C23H24FNO/c1-22(2)21(23(22,3)4)20(26)18-14-25(19-8-6-5-7-17(18)19)13-15-9-11-16(24)12-10-15/h5-12,14,21H,13H2,1-4H3
Key:UXOFEILQVZFLRH-UHFFFAOYSA-N
FUB-144 (also known as FUB-UR-144 ) is an
indole -based
synthetic cannabinoid that is presumed to be a potent
agonist of the
CB1 receptor and has been sold online as a
designer drug .
[1] It is an analogue of
UR-144 and
XLR-11 where the pentyl chain has been replaced with fluorobenzyl.
Legal status
In the United States, FUB-144 was temporarily emergency scheduled by the DEA in 2019.
[2] and made a permanent
Schedule I Controlled Substance on April 7, 2022.
[3]
Sweden's public health agency suggested classifying FUB-144 as hazardous substance on March 24, 2015.
[4]
See also
References
Phytocannabinoids (
comparison )
Cannabibutols Cannabichromenes Cannabicyclols Cannabidiols Cannabielsoins Cannabigerols Cannabiphorols Cannabinols Cannabitriols Cannabivarins Delta-8-tetrahydrocannabinols Delta-9-tetrahydrocannabinols Delta-10-Tetrahydrocannabinols Miscellaneous cannabinoids Active metabolites
Endocannabinoids
Synthetic cannabinoid receptor agonists / neocannabinoids
Classical cannabinoids (dibenzopyrans) Non-classical cannabinoids Adamantoylindoles Benzimidazoles Benzoylindoles Cyclohexylphenols
Eicosanoids
Hydrocarbons Indazole carboxamides Indazole-3- carboxamides Indole-3-carboxamides Indole-3-carboxylates Naphthoylindazoles
Naphthoylindoles Naphthoylpyrroles Naphthylmethylindenes Naphthylmethylindoles Phenylacetylindoles Pyrazolecarboxamides Pyrrolobenzoxazines Quinolinyl esters Tetramethylcyclo- propanoylindazoles Tetramethylcyclo- propanoylindoles Tetramethylcyclo- propylindoles Others
Allosteric
CBR Tooltip Cannabinoid receptor
ligands
Endocannabinoid enhancers (inactivation inhibitors)
Anticannabinoids (antagonists/inverse agonists/antibodies)